Related Experiment Videos
Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts
S H Stein1, I N Dean, S Y Rawal
1Department of Periodontology, College of Dentistry, University of Tennessee Health Science Center, Memphis, TN 38163, USA. sstein@uthsc.edu
Journal of Periodontal Research
|April 6, 2011
Summary
Statins may influence bone metabolism by altering osteoprotegerin (OPG) and RANKL production in human gingival fibroblasts (HGFs). While interleukin-1β increased OPG, statins primarily affected the RANKL/OPG ratio under non-inflammatory conditions.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Statins (HMG-CoA reductase inhibitors) are widely used for cholesterol management.
- Emerging evidence suggests statins impact bone metabolism via RANKL, RANK, and OPG pathways.
- Understanding statin effects on OPG and RANKL in specific cell types is crucial.
Purpose of the Study:
- To investigate OPG and RANKL production in human gingival fibroblasts (HGFs).
- To assess the influence of interleukin-1β (IL-1β) on OPG and RANKL secretion.
- To determine the effects of statins on OPG and RANKL production in HGFs.
Main Methods:
- Human gingival fibroblasts (HGFs) were treated with atorvastatin or simvastatin.
- Cells were stimulated with IL-1β in serum-free conditions.
- OPG and RANKL concentrations in culture supernatants were quantified using ELISA.
Main Results:
- IL-1β significantly elevated OPG production by HGFs.
- A trend towards increased RANKL production was observed with IL-1β stimulation.
- Statins increased the constitutive RANKL/OPG ratio, with minimal impact on IL-1β-stimulated ratios.
Conclusions:
- IL-1β enhances OPG production in HGFs.
- Statins appear to influence RANKL/OPG balance, potentially favoring bone resorption under non-inflammatory conditions.
- Further research is needed to elucidate the precise role of statins in bone metabolism.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...